| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.83B | 54.33B | 54.60B | 52.80B | 53.75B | 57.36B |
| Gross Profit | 10.12B | 10.15B | 9.92B | 8.69B | 9.05B | 10.75B |
| EBITDA | 508.50M | 1.05B | 732.00M | 658.00M | 1.35B | 2.09B |
| Net Income | 93.00M | 420.00M | 84.00M | 120.00M | 613.00M | 1.28B |
Balance Sheet | ||||||
| Total Assets | 36.23B | 35.73B | 39.70B | 37.89B | 36.35B | 36.68B |
| Cash, Cash Equivalents and Short-Term Investments | 4.81B | 5.22B | 8.01B | 7.78B | 6.84B | 7.66B |
| Total Debt | 1.32B | 1.36B | 5.09B | 4.10B | 2.62B | 2.12B |
| Total Liabilities | 9.86B | 9.31B | 13.01B | 11.55B | 9.99B | 9.88B |
| Stockholders Equity | 26.36B | 26.41B | 26.69B | 26.34B | 26.36B | 26.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.08B | -1.19B | -600.00M | -1.20B | 2.74B |
| Operating Cash Flow | 0.00 | 1.13B | -71.00M | 647.00M | -1.02B | 2.86B |
| Investing Cash Flow | 0.00 | 55.00M | -345.00M | -968.00M | 0.00 | 479.00M |
| Financing Cash Flow | 0.00 | -3.99B | 638.00M | 1.24B | 139.00M | -1.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥14.65B | 6.89 | ― | 1.20% | -6.45% | 53.12% | |
73 Outperform | ¥70.10B | 17.44 | ― | 2.73% | 6.41% | 16.71% | |
63 Neutral | ¥8.62B | 23.33 | ― | 3.25% | -0.73% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥25.06B | 12.76 | ― | 3.42% | -21.21% | -55.72% | |
54 Neutral | ¥2.77B | -1.63 | ― | 4.68% | 3.64% | 37.31% | |
49 Neutral | ¥2.34B | 27.61 | ― | ― | 14.60% | ― |